TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
SRZN

Surrozen Inc

Healthcare · Biotechnology

16.20$ -8.2% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SRZN
Line item 2019 2020 2021 2022 2023 2024 2025
– +46.1% +121.0% -34.8% -48.5% +5.2% +103.7%
– +70.7% +109.4% -22.7% -49.4% -5.3% +135.2%
– +20.2% -5.4% -25.4% +46.0% -4.1% +158.2%
– +69.0% +107.1% -25.5% -52.5% -4.1% +158.2%
– – – – +8.8% +18.1% -91.8%
– – – – – – –
– -9.7% -17.7% – – – –
– +12.7% +86.0% -51.1% -39.4% +757.5% +310.2%
– +86.6% +86.5% -28.3% -26.6% +2.3% +35.7%
– +40.4% +4.0% +1.5% +12.2% -26.8% -29.5%
– +82.7% +53.0% -75.8% -20.2% -41.7% +137.9%
– +60.9% +132.0% -30.7% -50.1% -156.4% –
– – – – – – –
– +102.3% +193.6% -0.9% -12.8% +45.3% +155.0%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?